×
This post has expired! It was posted more than 90 days ago.
<- Back

159844 - GPCE - Getting to grips with guidelines - a new approach to first injectables in type 2 diabetes

  • : Online

Recent international treatment guidelines now recommend first using GLP-1 receptor agonists (GLP-1 RAs) in preference to insulin for most people with type 2 diabetes requiring injectable therapy. This session will review the evidence for this important update and discuss appropriate patient selection and considerations, as well as locally available treatment options for the general practitioner. 

Relevance to General Practice

The GPCE offers GP delegates over 50 topic choices over three days. The subjects span many therapeutic areas allowing GPs to self-select the topics of most interest to the individual and their practice.

Learning outcomes
  • Understand the best practice management methods outlined in the recent treatment guidelines for T2D
  • Apply new recommendations to prescribe GLP-1 receptor antagonists where appropriate and recommended
  • Ensure patient safety through appropriate follow-up, monitoring and titration of medications
  • Delivery
    Title
    159844 - GPCE - Getting to grips with guidelines - a new approach to first injectables in type 2 diabetes
    Location
    Provider Type
    Education Provider
    Duration
    1 hour
    Start Date
    13-Sep-2019
    End Date
    15-Sep-2019
    CPD Points
    1 hour
    Price
    Free
    Location
    Online
    Contact Phone
    Log in into view this field.
    Location Map View Map
    HealthcareLink